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Abstract 
A new simple, precise, and accurate, high-performance thin-layer chromatography method was developed for 
the simultaneous determination of Atenolol and Chlorthalidone in tablet dosage forms. In this method, TLC 
aluminum plates pre-coated with silica gel 60 F254used as the stationary phase. The mobile phase consisting 
of Methylene Chloride: methanol: Ammonia solution 25%, in the ratio of 8.8:1.3:0.1 v/v is used. The 
densitometry evaluation was done at wavelength 266 nm using Camag scanner III. The developed method 
shows a well resolution between two peaks Atenolol and Chlorthalidone with Rf values 0.115 (±0.03) and 
0.458(±0.03), respectively. The proposed method was validated as per International Conference on 
Harmonization (ICH) guidelines for parameters such as specificity, precision, accuracy, linearity, and 
ruggedness and reported the values. The linear regression analysis shows that the correlation coefficient R2 
value for Atenolol is 0.999 and 0.997, respectively. The mean percentage recovery values obtained for Atenolol 
is 101.4 and for Chlorthalidone is 98.4. The statistical analysis shows that this method is suitable for routine 
analysis for quantification of Atenolol and Chlorthalidone in single or combined dosage forms of formulations.  
Keywords: Atenolol, Chlorthalidone, High-performance thin-layer chromatography (HPTLC), densitometry, 
Validation. 
Introduction 
Atenolol and Chlorthalidone tablets are used to treat hypertension to lower the blood pressure and to 
minimize the risk of stroke of heart attack. Atenolol is beta blocker which affects the heart and maintains the 
circulation of blood. The chemical name is 4-[2'-hydroxy3'-[(1-methylethyl)amino]propoxy]-benzeneacetamide 
and molecular structure is C14H22N2O3 and molecular weight is 266.3 [1-4]. Chlorthalidone is diuretic and 
causes the body to get rid of extra salt and water which helps to relax the blood vessels. The chemical name is 
1-oxo-3-(3-sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline.  
The molecular formula is C14H11CIN2O4S and molecular weight is 338.7. The Chemical structure for Atenolol 
and Chlorthalidone are shown in below fig. 1 and fig.2 respectively. [5-13]. Atenolol and Chlorthalidone 
combination is prescribed as an oral dosage form as tablets and has been determined via well know analytical 
methods such as HPLC and UV Spectrometry[14-19]. However there is no any HPTLC method for 
quantification of Atenolol and chlothalidone in combined dosage form. The quantitative estimation of 
Atenolol and chlothalidone is done by using HPTLC technique.  
The mobile phase used is Methylene Chloride: methanol: Ammonia solution 25%, in the ratio of 8.8:1.3:0.1 v/v. 
The TLC Plate: Merck, HPTLC plates silica gel 60F 254 is used. the Camag  Automatic sampler-4 Applicator, TLC 
Scanner III, Twin trough Chamber TTC, 20cm x 10 cm, Camag, Muttenz, Switzerland, Camag Scanner III 
operated Server vision CATS-version 2.5.18053.1 used in this study. The developed HPTLC method has been 
validated as per ICH guidelines. [20] 
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After Literature review it is observed that there is no HPTLC method available for estimation and quantification 
of Atenolol and Chlorthalidone in combined dosage forms. 
 
Fig.1. Chemical Structure of Atenolol 
 
Fig.2. Chemical Structure of Chlorthalidone 
Materials and Methods 
The solvent and reagents, Methylene Chloride (Analytical Grade), Methanol (HPLC Grade) and Ammonia 
Solution (25%),that was used to dissolve the Drug/ API (Active Pharmaceutical Ingredient) and in the 
preparation of mobile phase was purchased from Merck Specialities Ltd. Mumbai, India. The Tenoric-100 
(Atenolol 100mg and Chlorthalidone 25mg Tablets) are purchased from market. 
Instrumentation 
The estimation and quantification of Atenolol and Chlorthalidone tablets was done by using Camag 
Autosampler-4 Applicator (Muttenz, Switzerland) equipped with twin trough chamber TTC, 20cm x 10 cm is 
used in the study. The pre-coated silica gel 60 F254 TLC Plates of Merck (Darmstadt, Germany) of 10 cm x 
10cm, 0.2mm thickness layer used stationary phase. Camag Scanner III operated Server vision CATS-version 
2.5.18053.1 used in this study. Microsyringe (Linomat syringe, Hamilton-Bonaduz Schweiz), UV chamber 
(Muttenz, Switzerland) were used in this study. 
Preparation of mobile phase 
The mobile phase used is Methylene Chloride: methanol: Ammonia solution 25%, in the ratio of 8.8:1.3:0.1 
v/v/v. 
Preparation of Standard Solution (Atenolol) 
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Prepared standard solution by weighing about 10mg of Atenolol and dissolved in 10mL of methanol and 
further diluted with methanol to get working concentration of standard solution, 1mg/mL of Atenolol. 
Preparation of Standard Solution (Chlorthalidone) 
Prepared standard solution by weighing about 25mg of Atenolol and dissolved in 10mL of methanol and 
further diluted with methanol to get working concentration of standard solution, 0.25mg/mL of Chlorhalidone. 
Preparation of Sample Solution  
Weighed and crushed 20 tablets into fine powder and transferred sample powder equivalent to 500mg of 
Atenolol into 100mL volumetric flask, added 60 mL of methanol, sonicated for 20 minutes to get dissolve the 
material with vigorous intermittent shaking for every 2-3 minutes of interval. Cool to attain the room 
temperature for 10 minutes. Diluted upto mark with methanol. Filtered through Whatmann filter no.1. Further 
diluted filtered solution to achieve the concentration of working sample solution having 1mg/mL of Atenolol 
and 0.25mg/mL of Chlorthalidone.  
Method Development and Optimization   
Initial experiments are conducted on Methylene chloride and methanol in the ratio of 8:2 (v/v), due to this 
dragging of peaks observed. Hence ammonium solution (25%) was incorporated with different composition 
and different ratios. The mobile phase consisting methylene chloride: methanol: ammonia solution (25%), 
8.8:1.3:0.1 (v/v/v) was used. A suitable volume of standard solution and sample solutions (µl) were spotted on 
HPTLC plate 10 mm from bottom and 10mm from side edges. Ascending development technique was used in 
twin trough chambers.   
The chamber was saturated with mobile phase for 20 minutes at room temperature at 25°C.The distance 
covered by solvent front took about 8 cm which took about 15 minutes. The spots are then evaluated by using 
Camag scanner III at wavelength 266 nm and operated Server vision CATS-version 2.5.18053.1. The 
quantification and estimation of components done by using intensity of reflected light and peak area 
responses are used for calculation and evaluation. The TLC procedure was developed and optimized for 
simultaneous estimation of Atenolol and Chlorthalidone.  
The mobile phase methylene chloride: methanol: ammonia solution (25%), 8.8:1.3:0.1 (v/v/v) shows good 
resolution and sharp and symmetrical peaks of Rf 0.115± 0.02 for Atenolol and 0.458 ± 0.02 for 
Chlorthalidone. Prewashing of plates are done by using methanol and dried and activated. The plates are 
saturated for 20 minutes to ensure improved the reproducibility and peak shape for both active components. 
The developed method was validated and used for determination of Atenolol and Chlorthalidone in 
formulation. 
Method Validation 
Specificity 
The specificity of the method was produced by analysing blank, sample solution and reference solution. There 
was good resolution between the two peaks of Atenolol and Chlorthalidone and the identification of bands for 
both the peaks was confirmed by comparing the Rf values and spectra of bands with those of standards. The 
typical reference densitograms of Atenolol and Chlorthalidone tablet are shown in Fig.3 and 5. Their values are 
described in Table 1. 
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Fig. 3: Reference solution of Atenolol 1mg/mL 
 
Fig. 4: Reference solution of Chlorthalidone 1mg/mL 
Table 1: Specificity data of Atenolol and Chlorthalidone 
Name Atenolol (Observed Rf) Chlorthalidone (Observed Rf) 
Reference Solution 0.115 0.458 
Blank ND ND 
Mobile Phase ND ND 
ND=Not Detected 
Precision 
The Precision of the method was expressed in terms of variation usually Percentage Relative Standard 
Deviation (%RSD). The intra-day precision and inter day precision was performed. Injection volume (2µl) was 
spotted of prescribed concentration of Atenolol and Chlorthalidone in the table 2, 3, 4 &5. 
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Table 2:  Intra-day precision for Atenolol 
R
e
c
o
v
e
ry
 
le
v
e
l 
C
o
n
c
e
n
tr
a
ti
o
n
 m
g
/m
L
 
A
re
a
 
O
b
se
rv
e
d
 
a
t 
e
a
c
h
 
sp
ik
e
d
 
le
v
e
l 
(A
re
a
 X
 
1
0
0
0
0
0
0
) 
M
e
a
n
 
S
td
. 
a
re
a
 
o
b
se
rv
e
d
 
(A
re
a
 
X
 
1
0
0
0
0
0
0
) 
%
 A
te
n
o
lo
l 
M
e
a
n
 
S
D
 
%
 R
S
D
 
50% 0.50 0.00183132 
0.00188559 
97.1 
96.1 0.88 0.91 50% 0.50 0.00180001 95.5 
50% 0.50 0.00180633 95.8 
100% 1.00 0.00335201 
0.00339924 
98.6 
99.6 0.89 0.89 100% 1.00 0.00339709 99.9 
100% 1.00 0.00340909 100.3 
150% 1.50 0.00500158 
0.00515544 
97.0 
97.8 0.64 0.66 150% 1.50 0.00505944 98.1 
150% 1.50 0.00505840 98.1 
 
Table 3: Intra-precision for Chlorthalidone 
R
e
c
o
v
e
ry
 
le
v
e
l 
c
o
n
c
e
n
tr
a
ti
o
n
 
m
g
/m
L
 
A
re
a
 
O
b
se
rv
e
d
 
a
t 
e
a
c
h
 
sp
ik
e
d
 
le
v
e
l 
(A
re
a
 
X
 
1
0
0
0
0
0
0
) 
M
e
a
n
 
S
td
. 
a
re
a
 o
b
se
rv
e
d
 
(A
re
a
 
X
 
1
0
0
0
0
0
0
) 
%
 
C
h
lo
rt
h
a
li
d
o
n
e
 
M
e
a
n
 
S
D
 
%
 R
S
D
 
50% 0.125 0.00372301 
0.00371633 
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99.9 0.28 0.28 50% 0.125 0.00370260 99.6 
50% 0.125 0.00370894 99.8 
100% 0.250 0.00709381 
0.00718807 
98.7 
97.3 1.40 1.44 100% 0.250 0.00689192 95.9 
100% 0.250 0.00699191 97.3 
150% 0.375 0.01023653 
0.0105803 
96.8 
96.1 0.59 0.62 150% 0.375 0.01011603 95.6 
150% 0.375 0.01014519 95.9 
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Table 4:  Inter-day precision for Atenolol 
R
e
c
o
v
e
ry
 l
e
v
e
l 
C
o
n
c
e
n
tr
a
ti
o
n
 
m
g
/m
L
 
A
re
a
 
O
b
se
rv
e
d
 
a
t 
e
a
c
h
 
sp
ik
e
d
 
le
v
e
l 
(A
re
a
 
x
 
1
0
6
) 
M
e
a
n
 
S
td
. 
a
re
a
 
o
b
se
rv
e
d
 
(A
re
a
 x
 1
0
6
) 
%
 A
te
n
o
lo
l 
M
e
a
n
 
S
D
 
%
 R
S
D
 
50% 0.500 0.001678256 
0.00171952 
97.6 
97.3 0.67 0.68 50% 0.500 0.00166095 96.6 
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97.4 0.44 0.45 100% 1.000 0.00339541 97.3 
100% 1.000 0.00341852 97.9 
150% 1.500 0.004863063 
0.00492820 
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98.0 1.20 1.22 150% 1.500 0.004761900 96.6 
150% 1.500 0.004865013 98.7 
 
Table 5: Inter-day precision for Chlorthalidone 
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50% 0.125 0.00349139 
0.00365353 
95.6 
96.3 0.94 0.98 50% 0.125 0.00350660 96.0 
50% 0.125 0.00355703 97.4 
100% 0.250 0.00659521 
0.00681256 
96.8 
97.2 0.93 0.96 100% 0.250 0.00657241 96.5 
100% 0.250 0.00669191 98.2 
150% 0.375 0.00961153 
0.00983030 
97.8 
97.5 0.82 0.85 150% 0.375 0.00949103 96.5 
150% 0.375 0.00964519 98.1 
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System Precision 
The system precision was performed by analysing the Standard solution of Atenolol and Chlorthalidone and 
the reproducibility was confirmed by calculating the mean area response, standard deviation and percentage 
relative standard deviation (% RSD). The %RSD obtained for six replication of Atenolol and Chlorthalidone are 
1.84 & 1.38 respectively. 
Recovery 
The accuracy of the developed method was performed by spiking known amounts of standards into placebo 
at 80%, 100% and 120% levels in triplicate. The amount of drug was calculated based on the amount of drug 
added and amount of drug found. The percentage recovery obtained for both the active was in between 95.0 
to 105.0. The recovery results for Atenolol and Chlorthalidone are as shown below in table 6 and 7 
respectively. 
Table 6: Recovery for Atenolol 
 
 
Recovery for Atenolol 
Recovery 
Level 
Concentration 
mg/mL 
Area Observed 
(Area x 106) 
Mean Area 
Observed 
(Area x 106) 
Mean Std. 
Area Observed 
(Area x 106) 
% 
Recovery 
80% 0.80 0.00291517 
0.00286664 0.002832694 101.2 80% 0.80 0.00283043 
80% 0.80 0.00285432 
100% 1.00 0.00339334 
0.003469173 0.003449723 100.6 100% 1.00 0.00350709 
100% 1.00 0.00350709 
120% 1.20 0.00410986 
0.00417101 0.004073838 102.4 120% 1.20 0.00434656 
120% 1.20 0.00405661 
 
Mean 101.4 
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Table 7: Recovery for Chlorthalidone 
Recovery for Chlorthalidone 
Recovery 
level 
Concentration 
mg/mL 
Area Observed 
(Area x 106) 
Mean  Area 
Observed 
(Area x 106) 
Mean Std. 
Area Observed 
(Area x 106) 
% 
Recovery 
80% 0.20 0.00603675 
0.006015073 0.005896492 102.0 80% 0.20 0.00600416 
80% 0.20 0.00600431 
100% 0.25 0.00709373 
0.007052403 0.007190783 98.1 100% 0.25 0.0070115 
100% 0.25 0.00705198 
120% 0.30 0.00792926 
0.008062887 0.008464155 95.3 120% 0.30 0.00815237 
120% 0.30 0.00810703 
    
Mean 98.4 
 
Linearity 
The Linear regression data for the calibration plots revealed good linear relationships between the responses 
and the injection volume for Atenolol and Chlorthalidone. The correlation coefficient obtained for Atenolol 
and Chlorthalidone are 0.999 and 0.9968 respectively. The linearity plots are shown in below fig.4 and fig.5. 
The values are described in below table 8 and table 9.  
 
Fig. 5: Linearity of Atenolol 
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Table 8: Linearity of Atenolol 
 
 
 
 
 
 
 
 
 
 
Fig. 6: Linearity of Chlorthalidone 
Table 9: Linearity of Chlorthalidone 
Linearity Level (%) Injection Volume (µL) Area observed 
1 1 0.00089 
2 2 0.00131 
3 3 0.00211 
4 4 0.00263 
5 5 0.00319 
6 6 0.00400 
Intercept 0.000184 
Slope 0.00062 
Correlation Coefficient 0.9968 
y = 0.00062x + 0.000184
R² = 1.00
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Linear (Series1)
Linearity Level (%) Injection Volume (µL) Area observed 
1 1 0.00110 
2 2 0.00176 
3 3 0.00253 
4 4 0.00330 
5 5 0.00394 
6 6 0.00454 
Intercept 0.000410667 
Slope 0.000700 
Correlation Coefficient 0.9990 
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Sample Analysis 
The market samples of Atenolol and Chlorthalidone Tablets were analysed by using the proposed method and 
calculated via the assay value for both Atenolol and Chlorthalidone. The results obtained are as summarized 
below in Table 10. 
Table 10: Assay of market Sample 
Atenolol 
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Sample-1 100 1.00 0.00296334 
0.003000783 
98.8 
98.0 
Sample-2 100 1.00 0.00291709 97.2 
Chlorthalidone 
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Sample-1 25 0.25 0.00670373 
0.00690783 
97.0 
97.8 
Sample-2 25 0.25 0.00681115 98.6 
 
Forced degradation 
Forced degradation study was performed under acid hydrolysis, base hydrolysis and peroxide degradation 
conditions. The degradation sample solutions of Atenolol and Chlorthalidone were prepared. For acid 
hydrolysis samples are treated using 5 mL of 1N HCl, heated on water bath at 70°C for 30 minutes, cooled and 
neutralized the solution with 1N NaOH. For base hydrolysis samples are treated using 5 mL of 1N NaOH, 
heated on water bath at 70°C for 30 minutes, cooled and neutralized the solution with 1N HCl. 
In peroxide degradation of sample, added 30% H2O2 solution and heated on water bath at 70°C for 30 
minutes. It was observed that there is no any secondary peak generated for Atenolol and Chlorthalidone. The 
peroxide degradation shows little degradation. The results are summarized in below table 11. 
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Table 11: Forced Degradation Study Data 
Atenolol 
Sample Condition 
Sample 
Wt. (mg) 
Concentration 
mg/mL 
Area Observed 
(x 1000000) 
% Assay 
Control as such 107.20 1.00 0.00304251 97.1 
Acid 
degradation 
5 mL 1N HCl @ 
70°C/30 min. 
105.40 1.00 0.00298256 96.8 
Base 
degradation 
5 mL 1N NaOH @ 
70°C/30 min. 
105.20 1.00 0.00294567 95.7 
Peroxide 
degradation 
2 mL 30% H2O2 @ 
70°C/30 min. 
106.80 1.00 0.00302512 96.9 
Chlorthalidone 
Sample Condition 
Sample 
Wt. (mg) 
Concentration 
mg/mL 
Area Observed 
(x 1000000) 
% Assay 
Control as such 107.20 0.25 0.00690824 98.6 
Acid 
degradation 
5 mL 1N HCl @ 
70°C/30 min. 
105.40 0.25 0.00671245 97.4 
Base 
degradation 
5 mL 1N NaOH @ 
70°C/30 min. 
105.20 0.25 0.00669421 97.3 
Peroxide 
degradation 
2 mL 30% H2O2 @ 
70°C/30 min. 
106.80 0.25 0.00675651 96.8 
 
Conclusion 
The proposed HPTLC method was validated as per ICH guidelines. The analysis for combined dosage form was 
observed highly reliable and reproducible. As there were no prior HPTLC methods available for determination 
of combination of drug products containing Atenolol and Chlorthalidone; the proposed method can be 
adapted for routine analysis of Atenolol and Chlorthalidone in pharmaceutical dosage forms. 
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